Liquid biopsy is a non-invasive diagnostic and monitoring method that obtains tumor-related information from a patient's bodily fluids, such as blood, urine, or saliva.
It is widely utilized for patient convenience during cancer screening processes that require multiple tests.

Cytogen provides comprehensive profiling services, including the isolation of live circulating tumor cells (CTCs) and the identification of these cells.

Through high-level research and clinical applications worldwide, Cytogen is applying its technology to various clinical fields, such as cancer diagnosis, prognosis, metastasis prediction, and treatment response monitoring.